The FDA approved the first generic version of Xofluza (baloxavir marboxil) on June 17, clearing Norwich Pharmaceuticals’ single-dose influenza tablet ahead of the 2026–27 flu season. Generic baloxavir marboxil is approved to treat acute uncomplicated influenza in patients 5 and…
The Latest
Most emergency department patients surveyed across 10 U.S. emergency departments were not up to date on annual influenza vaccination, according to a study published June 17 in the Journal of Emergency Medicine. Researchers surveyed 3,285 adult patients between April and…
Phoenix-based Banner Health has appointed Mark Whalen executive vice president and chief enterprise growth officer, effective Aug. 1. Four things to know: 1. In this role, Mr. Whalen will lead efforts to expand access and value-based care across Banner’s six-state…
Artificial intelligence is increasingly becoming part of everyday pharmacy operations at Salt Lake City-based Intermountain Health, where more than 300 AI tools are now in use across the health system. Several of those tools have been deployed within pharmacy services,…
Citing “strategic advances in technology,” Springfield, Mo.-based CoxHealth is eliminating 53 revenue cycle roles, a system spokesperson confirmed to Becker’s on June 17. The cuts affect about 0.38% of CoxHealth’s workforce, the spokesperson said in a statement shared with Becker’s.…
Scott Kashman has been named CEO of Jacksonville, Fla.-based Ascension St. Vincent’s Health System, effective July 1, according to a June 18 LinkedIn post. In his new role, Mr. Kashman will oversee Ascension St. Vincent’s four hospitals, more than 90…
This episode recorded live at the Becker’s 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Dr. Nicholas Grosso, President, The Centers for Advanced Orthopaedics. He discusses the launch of MedVanta, the importance of…
In this episode, Michelle Stansbury, Associate Chief Innovation Officer and Vice President of IT Applications at Houston Methodist, joins the podcast to discuss the organization’s digital priorities for 2026 and the technologies shaping the future of healthcare delivery. She shares…
A novel EHR-based marker can identify transplant patients at high risk of organ rejection from medication nonadherence, researchers from New York City-based Mount Sinai Health System and Houston-based Texas Children’s found. The multicenter randomized controlled trial, published June 15 in…
IRhythm Holdings, the maker of the Zio cardiac monitoring patch, has identified a cybersecurity incident and launched an investigation with outside experts. IRhythm reported June 15 that it activated its incident response plans after detecting the breach, working with external…